Some studies have shown that FUS and TDP-43 interact and colocalize in neuronal inclusion bodies in patients with ALS and FTD, inducing neurodegeneration, suggesting a potential synergistic effect in disease progression [347–349]. Here, TARDBP is linked to amyotrophic lateral sclerosis.